Ultrasound measurement of peripheral endothelial dysfunction in type 2 diabetic patients: Correlation with risk factors

Bosnian Journal of Basic Medical Sciences

Volumn 10, Issue 2, 2010, Pages 84-88

  Bosevski, Marijan ^a   Georgievska Ismail, Ljubica ^a  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Endothelial dysfunction; Type 2 diabetes; Ultrasound

Indexed keywords

EID: 77953753283     PISSN: 15128601     EISSN: None     Source Type: Journal    
DOI: 10.17305/bjbms.2010.2699     Document Type: Article

References (22)

1. Panes J., Salas A, Microvascular pathobiology in Diabetes. In: Schmid-Schonbein G. W., Granger D. N. (eds). Molecular Basis for Microcirculatory Disorders, Springer-Verlag, New York, 2003
2. Beckman J. Endothelial Dysfunction. In: Marso S., Stern D. (eds). Diabetes and Cardiovascular Disease. Lippincot Williams & Wilkins, Philadelphia, 2004
3. Pieper G. M, Hyperglycemia and Diabetes-Induced Vascular Dysfunction: Role of Oxidative Stress. In: Keaney J. F. (ed) Oxidative Stress and Vascular' Disease. Kluwer Academic Publishers. Boston 2000
4. Scahalkwijk C. G., Poland D. C., van Dijk W., et al. Plasma concentration of C-reactive protein is increased in diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologica 1999;42(3)351-357
5. Kidawa M., Krzeminska-Pakula M., Peruga I. Z., Kasprzak J. D. Arterial dysfunction in syndrome X: results of arterial reactivity and pulse wave propagation tests. Heart 2003;89:422-426.
6. Enderle M. D., Benda N., Schmuelling R. M., Haering H. U., Pfohl M. Preserved endothelial function in I. DDM patients, but not in NIDDM patients, compared to healthy subjects. Diabetes Care 1998;21:271-277.
7. Ceriello A., Assalani R., Da Ros R., et al. Effect of atorvastatin and ibersartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetes. Circulation. 2005;11(19):2518-2524
8. Beishuizen E., Tamsa J., Wouter Jukema J., et al. The effect of statin therapy in endothelial function in type 2 diabetes without manifest cardiovascular disease. Diabetes Care. 2005;28(7)11668-1673
9. Thomas G. N., Chook P., Qiao M., Huang X. S., Leong H. C., Celermajer D. S., Woo K. S. Deleterious impact of high normal glucose levels and other metabolic syndrome componennts on arterial endothelial function and intima-media thickness in apparently healthy Chinese subjects: The CATHAY Study. Artenoscler. Thromb. Vasc. Biol, 2004;34:739-743
10. Leeson P., Thorne S., Donald A., Mullen M., Clarkson P., Deanfield J. Non-invasive measurement of endothelial function: effect or brachial artery dilatation of graded endothelial dependent and independent stimuli. Heart 1997: 78: 22-27
11. Bhagat K., Hingorami A., Vallance P. Flow associated or flow mediated dilatation? More than just semantics. Heart 1997;78:7-8.
12. De Vriese A. S., Verbeuren T. T., Van de Voorde J., Lameire N. H., Vanhoutte P. M. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 2000;130:963-974.
13. Piatti P. M., Ragasso G., Monti L. D., et. al. Endothelial and metabolic characteristics of pts with angina and angiographicaly normal coronary arteries : comparison with subjects with insulin resistance syndrome and normal controls, JACC 1999;34:1452-1460
14. Celermajer D. S., Sorensen K. E., Bull C., et al. Endothelium dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. JACC 1994;24:1468-1474.
15. Stamler J., Vaccaro O., Neaton J. et al. Diabetes, other risk factors, and. 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial (MRFIT) Diabetes Care 1993;16:434-324.
16. Greenwald SE, Ageing of the conduit arteries. J. Pathol. 2007;211(2):157-172
17. Bosevski M., Georgievska-Ismail Lj., Tosev S., Borozanov V. Risk factors for development of peripheral and carotid artery disease among type 2 diabetic patients. Prilozi. 2009;30(1):81-90.
18. Bagg W., Whaley G. A., Gamble G., et al. Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes. Intern. Med J. 2001;31(6):322-328 (Pubitemid 34225185)
19. Stokic E., Deric M., Radak D. Endothelial dysfunction and diabe tes. Med. Pregled 2005; 58 (9-10) : 459-464
20. Landmesser U., Hornig B., Drexier H. Endothelial dysfunction: a critical determinant in atherosclerosis? Circulation. 2004: 109 (21 Suppl 1) : 29-33
21. Bosevski M., Borozanov V., Tosev S., G-ieorgievska-Ismail Lj. Is assessment of peripheral endothelial dysfunction useful tool for risk stratification of type 2 diabetic patients with manifested coronary artery disease? Int. J. Cardiol. 2009;131(2):290-292.
22. Kitta Y., Nakamura T., Kodama Y., et al. Endothelial vasomor dysfunction in the brachial artery is associated with late in-stent coronary restenosis. JACC 2005;46(4):648-655